- The 8 States Most Likely to Legalize Marijuana Next
- Dow 18,000: Why This Market Rally May Never Happen Again
- Express Scripts and AbbVie Drug-Pricing Deal Might Devastate Biotech Bull Market
- Gilead Sciences Is Not a Buy; It's Heading Lower on Price War: Jim Cramer
- BlackBerry Classic Review: A Bold Update for CrackBerry Fans
The legendary oilman says it's time to break our addiction on fuel oil and explore alternative energy sources.
The device maker reels in its full-year forecast.
The health insurer's earnings were affected by bad investments in the financial industry.
The deal was completed Mondayl when Longs shareholders agreed to accept it.
The orthopedic device maker reported strong gains in revenue and profits for the quarter.
The health insurer struggled with rising medical costs and investment losses during the quarter.
Jeffrey Rein retires two days after Walgreens made an unsuccessful attempt to take over Longs Drug Stores.
Longs Drug Stores finds itself looking again at CVC-Caremark's offer.
A ruling by regulators may put sales of the company's spinal device in jeopardy.
The company sees Hawaii as a key market.